1.93 USD
▼+0.06-8.10%
2026-08-03
市值
$75.58M
市盈率
—
EPS
-0.65
股息率
—
52 周区间
1.56 – 3.95
成交量
87.17K
Beta
0.97
目标价
5.50
52W 低 1.5652W 高 3.95
价格走势
公司简介
Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive an...